e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
The non-parmacological management of COPD exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Assessment and treatment of comorbidity: what efforts pay off?
W. Janssens (Leuven, Belgium)
Source:
Annual Congress 2011 - The non-parmacological management of COPD exacerbations
Session:
The non-parmacological management of COPD exacerbations
Session type:
Symposium
Number:
1660
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Janssens (Leuven, Belgium). Assessment and treatment of comorbidity: what efforts pay off?. Annual Congress 2011 - The non-parmacological management of COPD exacerbations
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Multidimensional approaches to asthma: the need to look beyond drug treatments
Source: Annual Congress 2010 - Breathing therapies for asthma
Year: 2010
High rates of over-treatment of COPD in primary care: What risks to patients and costs to health services?
Source: Annual Congress 2011 - Early diagnosis in primary care
Year: 2011
COPD management in primary care: what are the challenges?
Source: Annual Congress 2011 - PG18 Early detection of COPD: benefits and problems
Year: 2011
Stepping up the controller medication in asthma patients: Impact of various treatment options on costs
Source: Annual Congress 2011 - The impact of the organisation of care on costs: the role of the physician in home care
Year: 2011
Integrated care: the Dutch experience
Source: Annual Congress 2011 - How to integrate care: crossing European borders
Year: 2011
Quality of diagnostic and therapeutic services: how do we deliver and assess/monitor them?
Source: Annual Congress 2011 - Primary Care Day II: Quality of assessment and diagnosis
Year: 2011
The sustainability agenda and inhaled therapy: what do patients want?
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021
Compliance with guidelines for pharmacological treatment of COPD: Real-life analyses
Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010
Year: 2010
Rehabilitation: the sooner the better?
Source: Annual Congress 2011 - The non-parmacological management of COPD exacerbations
Year: 2011
Asthma treatment: state of the art
Source: Annual Congress 2011 - PG6 Paediatric asthma: state of the art
Year: 2011
Before hospital admission for an exacerbation, asthma patients don’t look alike!
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016
Impact of phenotyping upon treatment choices in childhood
Source: Annual Congress 2010 - A new understanding of childhood wheeze phenotypes
Year: 2010
Should we treat every patient with latent TB? Is there a cost to pay?
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Prediction of mortality: what variables should we consider?
Source: Annual Congress 2011 - The prognostic value of cardiopulmonary exercise testing
Year: 2011
The individual social and financial burden of COPD
Source: Annual Congress 2011 - The COPD patient experience: care and management
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept